Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season

Schmitt, 2015, Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study, J Allergy Clin Immunol, 136, 1511, 10.1016/j.jaci.2015.07.038 Pfaar, 2014, Allergo J Int, 23, 282, 10.1007/s40629-014-0032-2 Jutel, 2015, International consensus on allergy immunotherapy, J Allergy Clin Immunol, 136, 556, 10.1016/j.jaci.2015.04.047 Senna, 2014, Allergen immunotherapy adherence in the real world: how bad is it and how can it Be improved?, Curr Treat Options Allergy, 2, 39, 10.1007/s40521-014-0037-6 Kiel, 2013, Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy, J Allergy Clin Immunol, 132, 353, 10.1016/j.jaci.2013.03.013 Incorvaia, 2016, Adherence to sublingual immunotherapy, Curr Allergy Asthma Rep, 16, 12, 10.1007/s11882-015-0586-1 Passalacqua, 2013, Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis, Clin Exp Allergy, 43, 22, 10.1111/j.1365-2222.2012.04052.x Köberlein, 2012, A causal treatment for grass pollen-induced allergic rhinoconjunctivitis, Immunotherapy, 5, 13, 10.2217/imt.12.147 Passali, 2010, Safety, tolerability and efficacy of sublingual allergoid immunotherapy with three different shortened up-dosing administration schedules, Acta Otorhinolaryngol Ital, 30, 131 Dahl, 2006, Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis, Allergy, 61, 185, 10.1111/j.1398-9995.2005.00949.x Jin, 2017, Sublingual immunotherapy dosing regimens: what is ideal?, J Allergy Clin Immunol Pract, 5, 1, 10.1016/j.jaip.2016.09.027 2008 Bonertz, 2018, Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: an analysis from the EAACI AIT Guidelines Project, Allergy, 73, 816, 10.1111/all.13357 Cox, 2010, Speaking the same language: the world allergy organization subcutaneous immunotherapy systemic reaction grading system, J Allergy Clin Immunol, 125, 569, 10.1016/j.jaci.2009.10.060 Passalacqua, 2013, Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language, J Allergy Clin Immunol, 132, 93, 10.1016/j.jaci.2013.03.039 Sieber, 2010, Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis, Curr Med Res Opin, 26, 925, 10.1185/03007991003659483 Sieber, 2011, Specific immunotherapy for allergic rhinitis to grass and tree pollens in daily medical practice-symptom load with sublingual immunotherapy compared to subcutaneous immunotherapy, Ann Med, 43, 418, 10.3109/07853890.2011.595426 Bousquet, 2008, Allergic rhinitis and its Impact on asthma (ARIA) 2008 update (in collaboration with the world health organization, GA(2)LEN and AllerGen), Allergy, 63, 8, 10.1111/j.1398-9995.2007.01620.x Liedtke, 2018, RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients, Allergy, 73, 1101, 10.1111/all.13362 Kemmerich, 2007, Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial, Arzneimittelforschung, 57, 607 Bastl, 2014, Development of a symptom load index: enabling temporal and regional pollen season comparisons and pointing out the need for personalized pollen information, Aerobiologia, 30, 269, 10.1007/s10453-014-9326-6 Cohen, 1992, A power primer, Psychol Bull, 112, 155, 10.1037/0033-2909.112.1.155 Hedges, 1985 Calderón, 2017, European survey on adverse systemic reactions in allergen immunotherapy (EASSI): a real-life clinical assessment, Allergy, 72, 462, 10.1111/all.13066 Rodriguez Del Rio, 2017, The European survey on adverse systemic reactions in allergen immunotherapy (EASSI): a paediatric assessment, Pediatr Allergy Immunol, 28, 60, 10.1111/pai.12660 Cox, 2006, Accelerated immunotherapy schedules: review of efficacy and safety, Ann Allergy Asthma Immunol, 97, 126, 10.1016/S1081-1206(10)60003-8 Bernstein, 2011, Systemic reactions to subcutaneous allergen immunotherapy, Immunol Allergy Clin N AM, 31, 241, 10.1016/j.iac.2011.02.007 Serrano, 2009, Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study, Ann Allergy Asthma Immunol, 102, 247, 10.1016/S1081-1206(10)60088-9 Tabar, 2005, Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus, J Allergy Clin Immunol, 116, 109, 10.1016/j.jaci.2005.05.005 Tabar, 1999, Dermatophagoides pteronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy, J Investig Allergol Clin Immunol, 9, 155 Moreno, 2003, Tolerance of a cluster schedule on the treatment of seasonal allergic respiratory disease with pollen extracts quantified in mass units, J Investig Allergol Clin Immunol, 13, 221 Schubert, 2009, Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy, Int Arch Allergy Immunol, 148, 251, 10.1159/000161585 Pfaar, 2009, Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens, Int Arch Allergy Immunol, 150, 102, 10.1159/000210436 Subiza, 2008, Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment, Clin Exp Allergy, 38, 987, 10.1111/j.1365-2222.2008.02995.x Nolte, 2018, The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases, Allergol Int, 67, 301, 10.1016/j.alit.2018.03.008 Didier, 2015, Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score, Clin Transl Allergy, 5, 12, 10.1186/s13601-015-0057-8 Mösges, 2010, Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais(R) tablets, Acta Dermatovenerol Alpina Pannonica Adriatica, 19, 3 Ott, 2009, Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study, Allergy, 64, 179, 10.1111/j.1398-9995.2008.01875.x Worm, 2014, Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study, Clin Transl Allergy, 4, 7, 10.1186/2045-7022-4-7 Klimek, 2014, A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations, Clin Transl Allergy, 4, 23, 10.1186/2045-7022-4-23 Pfaar, 2016, A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study, Allergy, 71, 99, 10.1111/all.12760 Senna, 2013, Safety and tolerability of sublingual immunotherapy in clinical trials and real life, Curr Opin Allergy Clin Immunol, 13, 656, 10.1097/ACI.0000000000000007 Roberts, 2017 Bastl, 2018, The connection of pollen concentrations and crowd-sourced symptom data: new insights from daily and seasonal symptom load index data from 2013 to 2017 in Vienna, World Allergy Organization Journal, 11, 24, 10.1186/s40413-018-0203-6 Bastl, 2016, First comparison of symptom data with allergen content (Bet v 1 and Phl p 5 measurements) and pollen data from four European regions during 2009-2011, Sci Total Environ, 548–549, 229, 10.1016/j.scitotenv.2016.01.014 Shah-Hosseini, 2017, Management of grass pollen allergy with 5-grass pollen tablet: results of a 2-year real-life study, Adv Ther, 34, 1382, 10.1007/s12325-017-0535-6 Pfaar, 2018, Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinoconjunctivitis, Allergy, 73, 187, 10.1111/all.13240